risks of glp 1 inhibitors The cardiovascular effects GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action GLP-1s may reduce cancer risk

In addition, KPV expands research applications

Commonly described short-term effects include water retention , tingling or numbness in the extremities, transient headaches , lightheadedness, flushing at injection sites, and increased hunger (more pronounced with less selective GHRPs than with ipamorelin)

If you want a deeper breakdown of this specific side effect, our guide on tirzepatide fatigue causes, mechanisms, and solutions is a helpful companion read

J Pediatr 159(5):851858.e1 Fatemi A, Wilson MA, Johnston MV (2009) Hypoxic-ischemic encephalopathy in the term infant

Rogan has discussed these compounds with various guests, acknowledging their effectiveness while raising questions about long-term use and potential drawbacks

But the cagrilintide doesnt seem to have that same pronounced effect to activate these neurons that are responsible for GI symptomatology